1.00 / AMA PRA Category 1 CreditTM 1.00 / CE for Nurse Practitioners
Jointly provided by Global Education Group and Physicians' Education Resource®, LLC (PER®)
This educational activity is supported by an independent medical educational grant from Shire.
During this Medical Crossfire®, expert faculty in the field of endocrinology will engage in a roundtable discussion that includes an endocrinologist, an endocrine surgeon, a physician assistant, and a primary care professional to discuss the most recent developments in the diagnosis and management of hypoparathyroidism. Unlike primary hyperparathyroidism, which is relatively common, hypoparathyroidism has not received the same level of attention and discussion until recently, as new guidelines have been developed to help clinicians diagnose, evaluate, and manage this disorder. Concomitantly, the recent approval of recombinant human PTH replacement therapy is expected to result in dramatic changes to the treatment landscape for this condition. This panel discussion includes experience-based strategies for improving diagnosis, highlights of the new treatment guidelines and both conventional and novel treatment pathways. The program concludes with case studies to demonstrate the application of the new evidence-based guidelines.
Endocrinologists, surgeons, internists, and other healthcare professionals with an interest in hypoparathyroidism
At the conclusion of this activity, participants should be better able to:
Articulate the burden, clinical presentation, and diagnostic features of hypoparathyroidism
Determine the benefits and challenges of conventional treatment with calcium and vitamin D
Explain the efficacy, safety, and role of parathyroid hormone replacement therapy in the management of hypoparathyroidism
Integrate new guidelines on the diagnosis and management of hypoparathyroidism
Disclosure of Conflicts of Interest Policy
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations
Chair/Moderator Stephen Brunton, MD Executive Director Primary Care Metabolic Group Los Angeles, California
Dr. Brunton has no relevant financial relationships with commercial interests to disclose.
Peter Angelos, MD, PhD, FACS Linda Kohler Anderson Professor of Surgery and Surgery Ethics Chief, Endocrine Surgery Associate Director, MacLean Center for Clinical Medical Ethics The University of Chicago Chicago, Illinois
Dr. Angelos has no relevant financial relationships with commercial interests to disclose.
Ji (CJ) Chun, PA-C, MPAS Physician Assistant, OptumCare Medical Group: Endocrinology Orange County, CA President, American Society of Endocrine Physician Assistants Adjunct Faculty, A.T. Still University/Arizona School of Health & Sciences Mesa, Arizona
Mr. Chun has no relevant financial relationships with commercial interests to disclose.
Aliya Khan, MD, FRCPC, FACP, FACE Professor of Clinical Medicine, Division of Endocrinology and Metabolism Director of Calcium Disorders Clinic Director, Fellowship in Metabolic Bone Disease McMaster University Hamilton, Ontario
Dr. Khan discloses the following: Consultant: Amgen, Eli Lilly Grant/Research Support: Alexion, Amgen, Shire
Accredited Provider Disclosure
Global Education Group Planning Staff—Ashley Marostica, RN, MSN, Lindsay Borvansky, Kristen Delisi, NP, Andrea Funk, and Liddy Knight have no relevant financial relationships with commercial interests to disclose.
Publishing Staff Disclosures
Physicians' Education Resource®, LLC (PER®) Planning Staff—David Heckard, Maryjo Dixon, RPh, Jyoti Arya, PharmD, RPh, and Katie Pierson have no relevant financial relationships with commercial interests to disclose.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians' Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurse Practitioners
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024
This activity is accredited for 1.00 contact hour which includes 0.00 hour(s) of pharmacology.
Activity ID #2463E
This activity was planned in accordance with AANP CE Standards and Policies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PER do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.